However, in patients with FIGO stage IV endometrial cancer, PlGF serum levels were significantly increased (18.67±3.86 pg/ml) as compared to healthy subjects and patients with stage I disease (P<0.01 and P<0.05 respectively; Tukey-Kramer multiple comparison test) (Fig. 1). The gene discussed is PGF; the disease is endometrial cancer.